Table 4 Comparison of corresponding variables of CCT and ROTEM analysis. Agreement is indicated by Cohen’s kappa κ with corresponding p-value
A | |||||
Non-ACLF n = 55 | ACLF n = 22 | ||||
CT EXTEM | <80s | 96.4% | 81.8% | ||
> 80s | 3.6% | 18.2% | |||
PT (Quick) | > 50% | 80% | 45.5% | ||
< 50% | 20% | 54.6% | |||
Non-ACLF n = 55 | ACLF n = 22 | ||||
CT EXTEM | <80s | >80s | <80s | >80s | |
PT (Quick) | > 50% | 97.7% (43/44) | 2.3% (1/44) | 100% (10/10) | 0.0% (0/10) |
< 50% | 90.9% (10/11) | 9.1% (1/11) | 66.7% (1/12) | 33.3% (4/12) | |
κ / p | 0.098 / 0.28 | 0.313 / 0.04 | |||
B | |||||
Non-ACLF n = 55 | ACLF n = 22 | ||||
CT INTEM | < 240 s | 90.7% | 81% | ||
> 240 s | 9.3% | 19% | |||
aPTT | < 36 s | 98.1% | 66.7% | ||
> 36 s | 1.9% | 33.3% | |||
Non-ACLF n = 55 | ACLF n = 22 | ||||
CT INTEM | < 240 s | > 240 s | < 240 s | > 240 s | |
aPTT | < 36 s | 92.5% (50/54) | 7.5% (4/54) | 100% (14/14) | 0.0% (0/14) |
> 36 s | 0.0% (0/1) | 100% (1/1) | 42.9% (3/7) | 57.1% (4/7) | |
κ / p | 0.31 / 0.02 | 0.64 / 0.002 | |||
C | |||||
Non-ACLF n = 55 | ACLF n = 22 | ||||
MCF EXTEM | > 40 mm | 94.5% | 81.8% | ||
< 40 mm | 5.5% | 18.2% | |||
Platelets | > 50/nl | 92.7% | 68.2% | ||
< 50/nl | 7.3% | 31.8% | |||
Non-ACLF n = 55 | ACLF n = 22 | ||||
MCF EXTEM | > 40 mm | < 40 mm | > 40 mm | < 40 mm | |
Platelets | > 50/nl | 96.1% (50/52) | 3.9% (2/52) | 86.7% (13/15) | 13.3% (2/15) |
< 50/nl | 75% (3/4) | 25% (1/4) | 42.9% (3/7) | 57.1% (4/7) | |
κ / p | 0.24 / 0.07 | 0.46 / 0.03 | |||
D | |||||
Non-ACLF n = 55 | ACLF n = 22 | ||||
MCF FIBTEM | > 9 mm | 94.5% | 68.2% | ||
< 9 mm | 5.5% | 31.8% | |||
Fibrinogen | > 1.6 g | 89.1% | 50% | ||
< 1.6 g | 10.9% | 50% | |||
Non-ACLF n = 55 | ACLF n = 22 | ||||
MCF FIBTEM | > 9 mm | < 9 mm | > 9 mm | < 9 mm | |
Fibrinogen | > 1.6 g | 95.9% (48/50) | 4.1% (2/50) | 90.9% (10/11) | 9.1% (1/11) |
< 1.6 g | 83.3% (5/6) | 16.7% (1/6) | 45.5% (5/11) | 54.5% (6/11) | |
κ / p | 0.16 / 0.20 | 0.46 / 0.02 | |||